Vaginal Infection
30
1
1
19
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.7%
2 terminated out of 30 trials
90.5%
+4.0% vs benchmark
27%
8 trials in Phase 3/4
21%
4 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (30)
Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection
Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis
Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters
Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge
Effect of PreforPro® on Urinary and Vaginal Health
Research on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining
Impact of Maternity Napkins on the Incidence of Vaginal Infections in the Post-partum Period
Vaginal Stump Infection After Laparoscopic Hysterectomy
Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection
Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users
Evaluation of Breastmilk Microbiota as a Function for Immunity
Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women
Laparoscopic Versus Transvaginal Cuff Closure
Probiotics Role in HPV Cervico-vaginal Infection Clearance
Epidemiology of Abnormal Vaginal Discharge During Pregnancy
Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy
Multi-Center Study of New Medications to Treat Vaginal Infections
Multi-Center Study of New Medications to Treat Vaginal Infections
Multi-Center Study of New Medications to Treat Vaginal Infections
Interventional Study to Evaluate the Effect of the Oral Administration of L.Plantarum on Vaginal Microbiota